Financial statements Hemorosan
Balance sheet of Hemorosan
Company age:
Age:
13 y. 3 m. 20 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of HEMOROSAN
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 77 950,12 | 76 770,12 | 76 770,12 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 |
| B. Current assets | 77 950,12 | 76 770,12 | 76 770,12 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 77 950,12 | 76 770,12 | 76 770,12 |
| A. Equity | -181 833,80 | -181 963,80 | -181 963,80 |
| B. Liabilities and provisions for liabilities | 259 783,92 | 258 733,92 | 258 733,92 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.